ByTrending Posts
Can Medtronic’s AI-Enabled Devices Transform Outcomes Across Cardiac,…
Executive Summary Medtronic, a global leader in medical technology, is accelerating the integration of artificial intelligence and advanced…
Is Intuitive Surgical Advancing AI-Powered Robotic Surgery to…
Executive Summary Intuitive Surgical, a global pioneer in robotic assisted surgery, is accelerating the integration of artificial intelligence,…
Is Qure.ai Powering Real-World AI Applications Across Emergency,…
Executive Summary Qure.ai, a global leader in AI-powered medical imaging solutions, is advancing the adoption of clinical AI…
Can Lunit’s Diagnostic AI Translate Early Detection into…
Executive Summary Lunit, a global leader in AI-powered diagnostic imaging and decision support, has demonstrated accelerating adoption across…
Is Arterys Leading Cloud-Native AI in Medical Imaging…
Executive Summary Arterys, a pioneer in cloud-native medical imaging AI, is shaping the future of diagnostic workflows by…
Can Zebra Medical Vision (Zebra-AI) Drive Widespread Clinical…
Overview: Healthcare Intelligence Beyond Diagnostic Alerts Zebra Medical Vision (Zebra-AI) is emerging as a differentiated leader in AI-driven…
Is Aidoc Driving Clinical Adoption of AI in…
Executive Summary Aidoc, a pioneer in AI-assisted radiology and diagnostic workflow automation, continues to expand its footprint in…
Is Viz.ai Transforming Medical Diagnostics and Acute Care…
Executive Summary Viz.ai, a leader in AI‑enabled clinical diagnostics and workflow orchestration, is reshaping how acute care conditions—especially…
Is NVIDIA Powering the AI Revolution in Medical…
Executive Summary NVIDIA, the global leader in accelerated computing and AI infrastructure, is increasingly at the core of…
Trending Posts
Latest Stories
BioMarin’s Roctavian Withdrawal—$240M Q4 Charge, <200 U.S. Patients Served Amid Gene Therapy Market Reality Check
Published by BioNextAI Media – BioMarin Pharmaceutical Inc. voluntarily withdrew its pioneering hemophilia A gene therapy…
Boehringer’s Hernexeos Secures Record 44-Day FDA Nod via Priority Voucher—76% ORR in HER2-Mutant NSCLC Frontier
Published by BioNextAI Media – Boehringer Ingelheim’s HERNEXEOS (zongertinib tablets) snagged ultra-fast FDA accelerated approval in…
AbbVie’s $380M North Chicago API Expansion—300 Jobs, AI Boost for Neuroscience/Obesity Pipeline
Published by BioNextAI Media – AbbVie is injecting $380 million into two new active pharmaceutical ingredient…
Pfizer’s 1,200-GPU AI Blitz—$500M Bet to Slash 18-24 Month Timelines Across Pharma Value Chain
Published by BioNextAI Media – Pfizer is deploying over 1,200 NVIDIA H100/H200 GPUs in a $500-600…
Gallery
